Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Mar 27;5(2):39-42.
doi: 10.1002/cld.448. eCollection 2015 Feb.

Hepatitis B reactivation from immunosuppressive drug therapy: A global menace

Robert P Perrillo  1
Affiliations
Editorial

Hepatitis B reactivation from immunosuppressive drug therapy: A global menace

Robert P Perrillo. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
The graph displays the number of patients with HBV reactivation due to cancer chemotherapy on the x axis. The data were collected in an international survey of the AASLD membership and are based on reports from 99 health care providers (see reference 8 for further details). The countries of origin of the patients are to the left, followed by their race and type of malignancy. Other types of cancer included bone, brain, gastrointestinal, retinoblastoma, round cell, sarcoma, teratoma and four cases of hepatocellular carcinoma.
Figure 2
Figure 2
Clinical outcomes of HBV reactivation in 188 patients. This study revealed that interruption of cancer chemotherapy, defined as either delay in initiation or premature discontinuation, was common. Based on data presented in reference 10.
See this image and copyright information in PMC

References

    1. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroentrology 1991;100:182‐188. - PubMed
    1. Shouval D, Shibolet O. Immunosuppression and HBV reactivation. Semin Liver Dis 2013;33:167‐177. - PubMed
    1. Weinbaum CM, Williams I, Mast EE, Finelli L, Wasley A, Neitzel SM, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm.Rep 2008;57:1‐20. - PubMed
    1. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661‐662. - PubMed
    1. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012;57:167‐185. - PubMed

Publication types